Lucas S K, Elmer E B, Flaherty J T, Prodromos C C, Bulkley B H, Gott B L, Gardner T J
J Thorac Cardiovasc Surg. 1980 Jul;80(1):102-10.
To evaluate the myocardial protection afforded by multiple-dose versus single-dose administration of potassium cardioplegic solution, we studied 24 isolated feline hearts before, during, and after 1 hour of ischemic arrest. Intramyocardial gas tensions, ventricular function, histologic preservation, and postischemic myocardial edema were compared in hearts maintained at 27 degrees C during the ischemic period. Equal groups of hearts received no infusion of cardioplegic solution, a single dose of potassium solution at the onset of ischemia, or multiple infusions of the cardioplegic solution throughout the arrest period. During ischemia, single-dose cardioplegic administration resulted in less accumulation of myocardial carbon dioxide (Pmco2) than did hypothermia alone, reflecting a reduction in metabolic activity during ischemia. The fact that multiple-dose cardioplegia further reduced Pmco2 accumulation suggests an intermittent washout of metabolic end products. During reperfusion, hearts protected by multidose cardioplegia demonstrated superior preservation of ventricular performance compared to hearts protected by single-dose cardioplegia or hypothermia alone. In addition, multiple infusions of the cardioplegic solution resulted in optimal structural preservation in both light and electron microscope studies.
为了评估多次剂量与单次剂量钾停搏液给药所提供的心肌保护作用,我们在24只离体猫心缺血停搏1小时的前、中、后进行了研究。比较了在缺血期维持于27℃的心脏的心肌内气体张力、心室功能、组织学保存情况以及缺血后心肌水肿。将同等数量的心脏分为未输注停搏液组、在缺血开始时给予单剂量钾溶液组以及在整个停搏期多次输注停搏液组。在缺血期间,单次剂量停搏液给药导致的心肌二氧化碳(Pmco2)蓄积比单纯低温时少,这反映了缺血期间代谢活性的降低。多次剂量心脏停搏进一步减少Pmco2蓄积这一事实表明代谢终产物被间歇性清除。在再灌注期间,与单次剂量心脏停搏或单纯低温保护的心脏相比,多次剂量心脏停搏保护的心脏在心室功能保存方面表现更优。此外,在光学显微镜和电子显微镜研究中,多次输注停搏液均导致了最佳的结构保存。